Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - AYTU BIOPHARMA, INC | v437748_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - AYTU BIOPHARMA, INC | v437748_ex31-2.htm |
| 10-Q - FORM 10-Q - AYTU BIOPHARMA, INC | v437748_10q.htm |
Exhibit 32.1
AYTU BIOSCIENCE, INC.
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing of the quarterly report on Form 10-Q for the quarter ended March 31, 2016 (the “Report”) by Aytu BioScience, Inc. (the “Company”), each of the undersigned hereby certifies that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: May 11, 2016 | /s/ Joshua R. Disbrow | ||
| Joshua R. Disbrow | |||
| Chief Executive Officer | |||
| Date: May 11, 2016 | /s/ Gregory A. Gould | ||
| Gregory A. Gould | |||
| Chief Financial Officer |